Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
Global Cord Blood Co. stock logo
CO
Global Cord Blood
$1.25
$1.34
$2.03
$5.50
$151.94M0.16216,519 shs2,303 shs
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$2.92
+1.7%
$2.65
$2.27
$4.65
$359.51M1.2276,871 shs48,370 shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$7.07
+2.2%
$8.46
$5.90
$10.71
$274.46M1.53157,946 shs217,374 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
Global Cord Blood Co. stock logo
CO
Global Cord Blood
0.00%0.00%0.00%-37.50%-58.19%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
+1.74%+4.29%+15.87%+3.18%+20.66%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
+2.17%-0.84%-14.41%-18.36%-32.41%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
Global Cord Blood Co. stock logo
CO
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
1.8801 of 5 stars
3.01.00.00.03.34.20.0
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
2.4695 of 5 stars
0.03.00.00.03.74.21.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/A
Global Cord Blood Co. stock logo
CO
Global Cord Blood
N/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.00
Hold$6.00105.48% Upside
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
4.00
Strong BuyN/AN/A

Current Analyst Ratings

Latest VMD, ARA, CO, and NAUT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2024
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 5/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
Global Cord Blood Co. stock logo
CO
Global Cord Blood
$1.24B0.12$0.30 per share4.19$6.34 per share0.20
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.99 per shareN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$194.05M1.41$0.84 per share8.46$3.00 per share2.36

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
Global Cord Blood Co. stock logo
CO
Global Cord Blood
$79.04M$0.641.95N/AN/AN/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$63.67M-$0.55N/AN/AN/AN/A-24.94%-21.70%8/7/2024 (Estimated)
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$10.24M$0.2627.19N/A5.32%9.32%6.79%8/14/2024 (Estimated)

Latest VMD, ARA, CO, and NAUT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/6/2024Q4 2023
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/A$0.09+$0.09$0.09N/A$50.74 million
2/28/2024Q4 2023
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.16-$0.14+$0.02-$0.14N/AN/A      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
Global Cord Blood Co. stock logo
CO
Global Cord Blood
$0.086.40%N/A12.50%N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
Global Cord Blood Co. stock logo
CO
Global Cord Blood
N/AN/AN/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
20.09
20.09
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.05
1.28
1.14

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
Global Cord Blood Co. stock logo
CO
Global Cord Blood
N/A
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
Global Cord Blood Co. stock logo
CO
Global Cord Blood
0.50%
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
42.50%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
19.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
Global Cord Blood Co. stock logo
CO
Global Cord Blood
1,202121.55 millionN/ANo Data
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
167125.27 million72.03 millionOptionable
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
99638.82 million31.37 millionNot Optionable

VMD, ARA, CO, and NAUT Headlines

Recent News About These Companies

VMD stock wins price target raise at Beacon
Viemed Healthcare Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

American Renal Associates logo

American Renal Associates

NYSE:ARA
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
Global Cord Blood logo

Global Cord Blood

NYSE:CO
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
Nautilus Biotechnology logo

Nautilus Biotechnology

NASDAQ:NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Viemed Healthcare logo

Viemed Healthcare

NASDAQ:VMD
Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.